The FDA wants the developers of medical devices that rely on AI to disclose more detail about how their devices were ...
An AI system developed to predict a patient's response to immunotherapy could help "democratize" access to the pricey drugs ...
The agency wants applicants to demystify their algorithms and provide specific details about what the models do, how they’re ...
The FDA’s guidance on AI in drug development points to potentially life-threatening consequences of the technology, highlighting the importance of providing the regulator with detailed information ...
This is a KFF Health News story. Preparing cancer patients for difficult decisions is an oncologist's job. At the University ...
The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI ...
Shares of the IBD 50's GeneDx surged Monday after the Food and Drug Administration issued guidance about using AI to develop ...